PHENOXYBENZAMINE HCL
ALPHA-BLOCKERS · PHEOCHROMOCYTOMA ADJUNCT THERAPY
RISING PHARM
Drug class
Pheochromocytoma treatment agents
Pheochromocytoma treatment agents refer to a therapeutic grouping of medications specifically employed to manage the clinical manifestations and hemodynamic instability associated with catecholamine-secreting neuroendocrine tumors. Read more about Pheochromocytoma treatment agents
10 drugs in this class 9 manufacturers
Drugs in Pheochromocytoma treatment agents
Filter & compare in the drug finder →
Opens the drug finder with Pheochromocytoma treatment agents preselected. Add indication or manufacturer filters there.
Pheochromocytoma treatment agents refer to a therapeutic grouping of medications specifically employed to manage the clinical manifestations and hemodynamic instability associated with catecholamine-secreting neuroendocrine tumors.
Rather than representing a single pharmacologic entity, this group primarily includes alpha-adrenergic receptor antagonists to counteract catecholamine-induced vasoconstriction, often supplemented by beta-adrenergic blockers to control reflex tachycardia, as well as catecholamine synthesis inhibitors like metyrosine that target tyrosine hydroxylase.
Clinically, these agents are indicated for the preoperative stabilization of patients undergoing tumor resection, the acute control of paroxysmal hypertensive crises, and the long-term palliative management of inoperable or metastatic pheochromocytomas and functional paragangliomas.
-
nih.gov
Pheochromocytoma treatment agents refer to a therapeutic grouping of medications specifically employed to manage the clinical manifestations and hemodynamic instability associated with catecholamine-secreting neuroendocrine tumors Rather than representing a single pharmacologic entity, this group primarily includes alpha-adrenergic receptor antagonists to counteract catecholamine-induced vasoconstriction, often supplemented by beta-adrenergic blockers to control reflex tachycardia, as well as ca...
-
merckmanuals.com
Pheochromocytoma treatment agents refer to a therapeutic grouping of medications specifically employed to manage the clinical manifestations and hemodynamic instability associated with catecholamine-secreting neuroendocrine tumors
-
rupahealth.com
Rather than representing a single pharmacologic entity, this group primarily includes alpha-adrenergic receptor antagonists to counteract catecholamine-induced vasoconstriction, often supplemented by beta-adrenergic blockers to control reflex tachycardia, as well as catecholamine synthesis inhibitors like metyrosine that target tyrosine hydroxylase
-
quickrxspecialty.pharmacy
Clinically, these agents are indicated for the preoperative stabilization of patients undergoing tumor resection, the acute control of paroxysmal hypertensive crises, and the long-term palliative management of inoperable or metastatic pheochromocytomas and functional paragangliomas
-
drugs.com
Clinically, these agents are indicated for the preoperative stabilization of patients undergoing tumor resection, the acute control of paroxysmal hypertensive crises, and the long-term palliative management of inoperable or metastatic pheochromocytomas and functional paragangliomas
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.